Clinical Trial Update: Interactive Voice Response Telephone Technology for the Treatment of Smoking in Patients With Heart Disease [Phase 2]

View source ↗

Summary

The document reports the completion of a Phase 2 trial evaluating Interactive Voice Response telephone technology for smoking cessation in patients with coronar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Interactive Voice Response Telephone Technology

Snippet

Sponsor: Ottawa Heart Institute Research Corporation | Conditions: Coronary Artery Disease | Phase 2 | Status: COMPLETED